Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung
Open Access
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 36, 114-123
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Pharmacokinetic and Pharmacodynamic Principles of Anti-infective DosingClinical Therapeutics, 2016
- Defining Antibiotic Dosing in Lung InfectionsClinical Pulmonary Medicine, 2013
- Penetration of Anti-Infective Agents into PulmonaryEpithelial Lining FluidClinical Pharmacokinetics, 2011
- Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining FluidClinical Pharmacokinetics, 2011
- Antimicrobial chemotherapy and lung microdialysis: a reviewInternational Journal of Antimicrobial Agents, 2010
- Pharmacokinetic‐Pharmacodynamic Considerations in the Design of Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia Studies: Look before You Leap!Clinical Infectious Diseases, 2010
- Tissue concentrations: do we ever learn?Journal of Antimicrobial Chemotherapy, 2007
- Lung microdialysis—A powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)The AAPS Journal, 2005
- Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevanceAntimicrobial Agents and Chemotherapy, 1992
- Pulmonary disposition of antimicrobial agents: methodological considerationsAntimicrobial Agents and Chemotherapy, 1992